BHST
BioHarvest Sciences Inc.
BHST lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
BHST Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Unavailable |
BHST's revenue is currently stable, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
BHST PE Valuation
BHST has no meaningful PE right now: it lost money over the past year.
BHST Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect BHST's losses to shrink, with revenue growing.
BHST Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.54 | +$0.16 |
| Q1 2026 | -$0.62 | -$0.12 |
| Q4 2025 | -$0.63 | +$0.22 |
| Q3 2025 | -$0.68 | +$0.54 |
| Q2 2025 | -$0.70 | +$0.49 |
| Q1 2025 | -$0.50 | +$0.86 |
| Q4 2024 | -$0.85 | +$0.09 |
| Q3 2024 | -$1.22 | -$0.61 |
BHST is still losing money, but far less than before: $0.54 per share over the past year, against $1.36 at its worst in early 2024.
BHST Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $8.8M | +3.8% |
| Q1 2026 | $8.5M | +8.2% |
| Q4 2025 | $9.1M | +25% |
| Q3 2025 | $9.1M | +39% |
| Q2 2025 | $8.5M | +41% |
| Q1 2025 | $7.9M | +47% |
| Q4 2024 | $7.3M | +61% |
| Q3 2024 | $6.5M | +102% |
BHST's revenue has grown year over year every quarter since late 2020: $9M last quarter, up 3.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -28% | -7.1 points |
| Q1 2026 | -22% | +0.3 points |
| Q4 2025 | -12% | +11 points |
| Q3 2025 | -10% | +22 points |
| Q2 2025 | -21% | +8.1 points |
| Q1 2025 | -22% | +4.8 points |
| Q4 2024 | -23% | +33 points |
| Q3 2024 | -32% | +30 points |
BHST's operating margin was −28% last quarter, down 7.1 points from the same quarter a year ago.
BHST Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.3M | -$1.2M |
| Q1 2026 | -$2.2M | -$59K |
| Q4 2025 | -$2.9M | +$387.3K |
| Q3 2025 | -$2.5M | -$270.7K |
| Q2 2025 | -$2.1M | +$542.1K |
| Q1 2025 | -$2.1M | -$311K |
| Q4 2024 | -$3.3M | -$126.9K |
| Q3 2024 | -$2.3M | -$836K |
BHST has burned cash in almost every quarter: −$11M over the past year, against −$10M the year before.
BHST Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +477 shares |
| 1 year | +31% | +5.3M shares |
| 3 years | +69% | +9.2M shares |
| 5 years | +84% | +10.3M shares |
| Available history | +698% | +19.8M shares |
BHST has 23M diluted shares, up 31% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BHST hasn't bought back shares in the past year.
BHST Net Leverage
BHST's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BHST Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.6 | Neutral |
| Stochastic | 17.3 | Oversold |
BHST's weekly RSI is 33 (neutral) and its Stochastic is 17 (oversold).
BHST PE vs Industrials Sector
BHST has no meaningful PE right now: it lost money over the past year.
BHST Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.63 | 0% above |
| 20 week MA | $1.97 | 17% below |
| 50 week MA | $3.45 | 53% below |
| 100 week MA | $5.30 | 69% below |
BHST is in a downtrend: it's below all four of its weekly moving averages, and 69% below its 100-week average.
BHST Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $4.80 | $6.15 | +28% |
| 2025 | $6.15 | $5.33 | -13% |
| 2026 YTD | $5.33 | $1.63 | -69% |
BHST has finished lower in one of the last two years. It's down 69% so far in 2026.